Role of Artificial Intelligence in Biomarker Tests
Artificial intelligence (AI) is transforming the Biomarker Tests Market by enhancing data analysis and interpretation. AI algorithms can identify novel biomarkers and predict disease progression with higher accuracy.
Machine learning models integrate multi-omics data to provide comprehensive diagnostic insights. The fusion of AI with biomarker testing promises to accelerate discovery and improve clinical decision-making, propelling market growth.
11 Views